Journal of Clinical Endocrinology & Metabolism, Vol 54, 217-222, Copyright © 1982 by Endocrine Society

ARTICLES

Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics

H Hidaka, M Nagulesparan, I Klimes, R Clark, H Sasaki, SL Aronoff, B Vasquez, AH Rubenstein and RH Unger

Insulin secretion and insulin resistance were examined in seven obese type II diabetics before and after control of plasma glucose levels without weight loss. Control was achieved by regular insulin injection (60-205 U/day in four doses). After 10 days of therapy, plasma insulin and C-peptide responses to oral glucose were significantly improved. Insulin-induced glucose rates, estimated by the glucose clamp technique, averaged 1.08 +/- 0.30 mg/kg. min (mean +/- SEM; n = 7) before treatment and were unchanged (1.08 +/- 0.25) after treatment. These indicate that short term control of plasma glucose improved insulin secretion but not insulin sensitivity. The impaired insulin secretion and insulin sensitivity in type II diabetics appears to be, in part, secondary to metabolic abnormalities associated with hyperglycemia.

This article has been cited by other articles:

				H.-S. Chen, T.-E. Wu, T.-S. Jap, L.-C. Hsiao, S.-H. Lee, and H.-D. Lin Beneficial Effects of Insulin on Glycemic Control and {beta}-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy Diabetes Care, October 1, 2008; 31(10): 1927 - 1932. [Abstract] [Full Text] [PDF]

				L. Juurinen, M. Tiikkainen, A.-M. Hakkinen, A. Hakkarainen, and H. Yki-Jarvinen Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E829 - E835. [Abstract] [Full Text] [PDF]

				A. M. Chang, M. J. Smith, C. J. Bloem, A. T. Galecki, and J. B. Halter Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E906 - E911. [Abstract] [Full Text] [PDF]

				K. Yoshioka, T. Yoshida, and T. Yoshikawa Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes: Response to Ryan, Imes, and Wallace Diabetes Care, September 1, 2004; 27(9): 2281 - 2282. [Full Text] [PDF]

				E. A. Ryan, S. Imes, and C. Wallace Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Diabetes Care, May 1, 2004; 27(5): 1028 - 1032. [Abstract] [Full Text] [PDF]

				C. Anderwald, E. Bernroider, M. Krssak, H. Stingl, A. Brehm, M. G. Bischof, P. Nowotny, M. Roden, and W. Waldhausl Effects of Insulin Treatment in Type 2 Diabetic Patients on Intracellular Lipid Content in Liver and Skeletal Muscle Diabetes, October 1, 2002; 51(10): 3025 - 3032. [Abstract] [Full Text] [PDF]

				T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 462 - 468. [Abstract] [Full Text] [PDF]

				E. Ferrannini Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects Endocr. Rev., August 1, 1998; 19(4): 477 - 490. [Abstract] [Full Text] [PDF]

				E. Tozzo, L. Gnudi, and B. B. Kahn Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter Endocrinology, April 1, 1997; 138(4): 1604 - 1611. [Abstract] [Full Text] [PDF]